Corporate Results
-
Pharmaceuticals
Aurobindo Pharma net declines to Rs 55 cr
Our Bureau
Hyderabad, Jan. 30 Aurobindo Pharma Ltd has posted about 4.5 per cent dip in net profit at Rs 55.25 crore in the third quarter ended December 31, 2007 against Rs 60.12 crore in the same period of last fiscal year.
The total income, however, grew to Rs 549.4 crore (Rs 512 crore). The earnings per share stood at Rs 8.17 (Rs 8.79).
“The sales in the third quarter was impacted by lower offtake of semi-synthetic penicillin (SSP) products on account of fluctuation in Penicillin G Potassium prices and appreciation of rupee against the dollar,” the Hyderabad-based company said in a release.
The company had completed the transfer of products dossiers/intellectual property rights to its European subsidiary and the benefits of globalisation of IPRs would accrue in the coming years, it added.
The Chinese operations made positive contributions to the performance. “The company’s efforts to become an integrated global player have started yielding results. The formulations sales now constituted 40 per cent of total sales in the third quarter and are expected to increase in future,” the release said.
Related Stories:
US nod for Aurobindo products
Aurobindo gets UK certificate
Aurobindo Pharma on course to emerge global generic major
Domestic sales drive Aurobindo Q2 net up 86%
More Stories on :
Pharmaceuticals
Article
E-Mail
::
Comment
::
Syndication
::
Printer Friendly Page
|
